Pfizer Inc and BioNTech SE expects younger teens to be eligible for coronavirus vaccination in the fall, and elementary school children by the end of the year, the company’s chief executive Albert Bourla said on Thursday.In the United States, the vaccine is authorized for use in people aged 16 or older.
Bourla said the company plans to submit data for children aged 12 to 16 very soon.He said his assumption was that the vaccine should be authorized for that age range by the fall, adding that data on children aged 5 to 11 can be expected by year-end.